SCHEMBL8868192

SCHEMBL8868192

COC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(Oc3cccc(C(F)(F)F)c3)cc2)cn1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ P4HTM Q9NXG6 2/20 0.49
▸ MCL1 Q07820 10/20 0.48
▸ BCL2L1 Q07817 9/20 0.48
▸ MAPK14 Q16539 1/20 0.43
▸ KDR P35968 1/20 0.42
▸ MMP2 P08253 1/20 0.42
▸ MMP3 P08254 1/20 0.42
▸ MMP9 P14780 1/20 0.42
▸ MMP8 P22894 1/20 0.42
▸ MMP13 P45452 1/20 0.42
▸ MMP14 P50281 1/20 0.42
▸ SCN9A Q15858 2/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868123 0.90 BCL2L1 (0.49) P4HTMMCL1BCL2L1MAPK14KDR
SCHEMBL8869647 0.87 PGR (0.50) MAPK14KDRRAB9AMAPTGAA
SCHEMBL9143139 0.85 P4HTM (0.48) P4HTMMCL1BCL2L1KDRMMP2
SCHEMBL8870003 0.84 P4HTM (0.56) P4HTMMCL1BCL2L1KDRRAB9A
SCHEMBL8868467 0.82 P4HTM (0.71) P4HTMKDRMMP2MMP9MMP8
SCHEMBL9516252 0.82 BCL2L1 (0.50) P4HTMMCL1BCL2L1MAPK14MMP2
SCHEMBL9018320 0.82 RAB9A (0.49) P4HTMMCL1BCL2L1MMP2MMP3
SCHEMBL8869868 0.81 P4HTM (0.66) P4HTMRAB9A
SCHEMBL7870464 0.80 BCL2L1 (0.45) MCL1BCL2L1MAPK14MMP2MMP3
SCHEMBL8869937 0.79 P4HTM (0.52) P4HTMMCL1BCL2L1KDRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 — — US disclosed
Send feedback